Topic
FDA Approval
198 published works
Healthcare Law Insights
FDA Complete Response Letters: The design v. reality of FDA’s responses to drug applications
By Diane Romza-Kutz, Fredric Roth V
Recent trends in the U.S. Food and Drug Administration's ("FDA’s") utilization of Complete Response Letters (“CRLs”) would indicate there may be a disconnect between the intended use of CRLs and…
Health Law Prof Blog
Guest Blogger Associate Dean and Professor of Law Joan H. Krause: The Right to Try Meets the Reality of Drug Approval
Whether it be a social media campaign to convince a company to provide an experimental anti-viral drug to a young cancer patient suffering from a life-threatening infection or the debate…
Animal Law Update
Recognizing the Vital Contributions of Animals to Biomedical Research
There are a lot of myths circulated by animal rights activists about the use of animals in biomedical research, which they are opposed to, even when such research benefits the…
GlobalTort
The Pace of Science and Business – More Speed
By Kirk Hartley
Velocity continues to increase for turning cutting edge molecular biology into businesses and new treatments. On March 14, the UK announced fast advancing plans to emulate the US FDA's approach…
Dangerous Drugs & Medical Devices
FDA won’t say which drugs on the market were approved based on fraudulent research
This shows that the FDA is more interested in protecting pharmaceutical companies than patients. Note how Woodcock doesn’t want to force new trials because that requires human experimentation, which has…
Focus on Regulation
New FDA Draft Guidance on Dispute Resolution: An Important Appeal Pathway for Drug Companies
On March 13, 2013, FDA announced in the Federal Register the availability of an FDA draft guidance, titled “Formal Dispute Resolution: Appeals Above the Division Level.” Formal dispute resolution affords…
Drug & Device Law
Hail! Hail! To Michigan
By Bexis
Here's another guest post this time by Clem C. Trischler and Jason M. Reefer, of Pietragallo Gordon, about a recent litigation involving the Michigan immunity statute and when a "drug"…
DuetsBlog
FDA Trademark Approval
--Susan Perera, Attorney One aspect of trademark law that we haven’t discussed here at DuetsBlog is FDA approval of trademarks for pharmaceuticals. While there are certainly many benefits to federal…
Reproductive Rights Prof Blog
Stem-Cell-Based Drug Approved in Canada for Treatment of Graft-Versus-Host Disease
The New York Times: A Stem-Cell-Based Drug Gets Approval in Canada, by Andrew Pollack:In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in…
Supreme Court Update
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S (10-844), Mohamad v. Palestinian Authority (11-88) and Order List
By Kim Rinehart
The unanimous decisions continued last week with Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S (10-844), holding that a generic drug manufacturer may bring a counterclaim against a brand-name drug…